Neuberger Berman Group’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,637
| Closed | -$39.8K | – | 1858 |
|
|
2023
Q4 | $39.8K | Buy |
+10,637
| New | +$39.8K | ﹤0.01% | 1815 |
|
|
2022
Q4 | – | Sell |
-376,683
| Closed | -$8.44M | – | 1814 |
|
|
2022
Q3 | $8.44M | Sell |
376,683
-266
| -0.1% | -$5.96K | 0.01% | 776 |
|
|
2022
Q2 | $9.34M | Buy |
376,949
+18,757
| +5% | +$465K | 0.01% | 763 |
|
|
2022
Q1 | $13.9M | Buy |
358,192
+5,856
| +2% | +$227K | 0.01% | 746 |
|
|
2021
Q4 | $20.6M | Sell |
352,336
-32,851
| -9% | -$1.92M | 0.02% | 683 |
|
|
2021
Q3 | $22.7M | Buy |
385,187
+124,894
| +48% | +$7.35M | 0.02% | 643 |
|
|
2021
Q2 | $22.6M | Buy |
260,293
+203,610
| +359% | +$17.7M | 0.02% | 672 |
|
|
2021
Q1 | $4.64M | Sell |
56,683
-4,317
| -7% | -$354K | ﹤0.01% | 969 |
|
|
2020
Q4 | $5.55M | Hold |
61,000
| – | – | 0.01% | 888 |
|
|
2020
Q3 | $2.44M | Buy |
61,000
+24,000
| +65% | +$959K | ﹤0.01% | 1028 |
|
|
2020
Q2 | $1.27M | Hold |
37,000
| – | – | ﹤0.01% | 1088 |
|
|
2020
Q1 | $822K | Sell |
37,000
-53,000
| -59% | -$1.18M | ﹤0.01% | 1132 |
|
|
2019
Q4 | $1.76M | Sell |
90,000
-17,400
| -16% | -$340K | ﹤0.01% | 1056 |
|
|
2019
Q3 | $1.67M | Buy |
107,400
+11,400
| +12% | +$177K | ﹤0.01% | 1051 |
|
|
2019
Q2 | $1.95M | Buy |
96,000
+36,000
| +60% | +$731K | ﹤0.01% | 1039 |
|
|
2019
Q1 | $1.05M | Hold |
60,000
| – | – | ﹤0.01% | 1108 |
|
|
2018
Q4 | $770K | Sell |
60,000
-60,000
| -50% | -$770K | ﹤0.01% | 1166 |
|
|
2018
Q3 | $1.96M | Buy |
120,000
+105,000
| +700% | +$1.71M | ﹤0.01% | 1037 |
|
|
2018
Q2 | $170K | Sell |
15,000
-138,250
| -90% | -$1.57M | ﹤0.01% | 1660 |
|
|
2018
Q1 | $1.5M | Sell |
153,250
-20,000
| -12% | -$195K | ﹤0.01% | 1075 |
|
|
2017
Q4 | $1.06M | Buy |
173,250
+40,250
| +30% | +$246K | ﹤0.01% | 1185 |
|
|
2017
Q3 | $527K | Buy |
133,000
+83,300
| +168% | +$330K | ﹤0.01% | 1286 |
|
|
2017
Q2 | $161K | Sell |
49,700
-18,900
| -28% | -$61.2K | ﹤0.01% | 1540 |
|
|
2017
Q1 | $312K | Buy |
+68,600
| New | +$312K | ﹤0.01% | 1403 |
|